Clinical trials
catalyst calendar across sponsors →Studies where MGPI is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional · 1 with posted results
Held by 13 tracked-famous managers (ARIEL INVESTMENTS, LLC, CITADEL ADVISORS LLC, TWO SIGMA INVESTMENTS, LP, AQR CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, +8 more) · FINRA short interest 5.5 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 2 sells · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Comparison of the Postprandial Glycemic and Insulinemic Response After a Fibersym Containing Cookie With a ControlNCT04820322results2025-01-222-hour Postprandial Glucose Incremental Area Under the Curve (IAUC)Randomized · Quadruple-masked · OtherStudy Protocol and Statistical Analysis Plan ↗ | Not applicable | Completed | Other: Fibersym, Control cookie | Postprandial Hyperglycemia | 16 | 2018-10-19actual | 2025-01-22 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19